$PCRX
Pacira Biosciences Inc

2023 Q3 Form 10-Q Financial Statement

#000139681423000037 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $163.9M $169.5M
YoY Change -2.11% 0.03%
Cost Of Revenue $39.75M $48.21M
YoY Change -21.56% -4.78%
Gross Profit $124.2M $121.3M
YoY Change 6.33% 2.08%
Gross Profit Margin 75.75% 71.55%
Selling, General & Admin $67.95M $64.85M
YoY Change 10.87% -0.24%
% of Gross Profit 54.72% 53.48%
Research & Development $20.83M $18.82M
YoY Change 7.34% -28.38%
% of Gross Profit 16.77% 15.52%
Depreciation & Amortization $4.100M $19.05M
YoY Change -29.31% 193.14%
% of Gross Profit 3.3% 15.71%
Operating Expenses $88.78M $98.00M
YoY Change 10.03% 7.35%
Operating Profit $17.72M $23.26M
YoY Change -16.76% -25.52%
Interest Expense $3.464M -$1.754M
YoY Change -64.85% -119.86%
% of Operating Profit 19.55% -7.54%
Other Income/Expense, Net -$1.120M -$269.0K
YoY Change -94.17% -97.08%
Pretax Income $16.60M $37.85M
YoY Change 702.37% 72.01%
Income Tax $5.743M $12.09M
% Of Pretax Income 34.59% 31.94%
Net Earnings $10.86M $25.76M
YoY Change -1666.81% 29.62%
Net Earnings / Revenue 6.62% 15.2%
Basic Earnings Per Share $0.23 $0.56
Diluted Earnings Per Share $0.23 $0.49
COMMON SHARES
Basic Shares Outstanding 46.42M shares 45.99M shares
Diluted Shares Outstanding 52.07M shares 52.05M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $235.2M $220.8M
YoY Change -28.45% -30.22%
Cash & Equivalents $99.12M $86.81M
Short-Term Investments $136.1M $134.0M
Other Short-Term Assets $18.60M $17.35M
YoY Change 29.02% -4.28%
Inventory $96.52M $92.13M
Prepaid Expenses
Receivables $96.96M $99.08M
Other Receivables $0.00 $0.00
Total Short-Term Assets $447.3M $429.3M
YoY Change -16.15% -18.41%
LONG-TERM ASSETS
Property, Plant & Equipment $175.8M $246.1M
YoY Change -9.22% 28.68%
Goodwill $163.2M $163.2M
YoY Change 3.68% 11.7%
Intangibles $497.6M $511.9M
YoY Change -14.36% -14.01%
Long-Term Investments $35.50M $35.63M
YoY Change -18.86% -0.52%
Other Assets $151.7M $156.1M
YoY Change -2.46% -6.59%
Total Long-Term Assets $1.087B $1.113B
YoY Change -9.47% -7.84%
TOTAL ASSETS
Total Short-Term Assets $447.3M $429.3M
Total Long-Term Assets $1.087B $1.113B
Total Assets $1.534B $1.542B
YoY Change -11.53% -11.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.51M $24.21M
YoY Change 27.67% 73.11%
Accrued Expenses $59.88M $65.20M
YoY Change -21.57% -15.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.600M $19.50M
YoY Change -74.61% -42.25%
Total Short-Term Liabilities $93.66M $108.9M
YoY Change -28.79% -18.22%
LONG-TERM LIABILITIES
Long-Term Debt $515.9M $532.2M
YoY Change -27.74% -26.28%
Other Long-Term Liabilities $11.95M $93.31M
YoY Change -37.5% 379.18%
Total Long-Term Liabilities $11.95M $625.5M
YoY Change -37.5% 3112.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $93.66M $108.9M
Total Long-Term Liabilities $11.95M $625.5M
Total Liabilities $702.9M $734.4M
YoY Change -27.1% -24.86%
SHAREHOLDERS EQUITY
Retained Earnings -$131.7M -$142.5M
YoY Change -5.04% 3.31%
Common Stock $46.00K $46.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $831.6M $808.0M
YoY Change
Total Liabilities & Shareholders Equity $1.534B $1.542B
YoY Change -11.53% -11.05%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $10.86M $25.76M
YoY Change -1666.81% 29.62%
Depreciation, Depletion And Amortization $4.100M $19.05M
YoY Change -29.31% 193.14%
Cash From Operating Activities $44.50M $43.50M
YoY Change 4.33% 45.94%
INVESTING ACTIVITIES
Capital Expenditures $3.400M $3.404M
YoY Change -165.62% -129.01%
Acquisitions
YoY Change
Other Investing Activities -$1.000M $10.73M
YoY Change -97.64% -65.27%
Cash From Investing Activities -$4.300M $7.326M
YoY Change -90.95% -61.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.80M 440.0K
YoY Change 257.56% -100.29%
NET CHANGE
Cash From Operating Activities 44.50M 43.50M
Cash From Investing Activities -4.300M 7.326M
Cash From Financing Activities -27.80M 440.0K
Net Change In Cash 12.40M 51.26M
YoY Change -198.12% -148.97%
FREE CASH FLOW
Cash From Operating Activities $44.50M $43.50M
Capital Expenditures $3.400M $3.404M
Free Cash Flow $41.10M $40.10M
YoY Change -14.08% -3.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
16613000 usd
CY2022Q2 pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
18058000 usd
pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
4506000 usd
pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
13721000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1672000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10955000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-36000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25763000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
807975000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10857000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1821000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11544000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-78000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
19876000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
756636000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1914000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1672000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22945000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
207000 usd
us-gaap Net Income Loss
NetIncomeLoss
6227000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
807975000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
730408000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21935000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1821000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22733000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-772000 usd
us-gaap Net Income Loss
NetIncomeLoss
26704000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
756636000 usd
us-gaap Net Income Loss
NetIncomeLoss
6227000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4100000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2193000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38656000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40897000 usd
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
1628000 usd
pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
2053000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
703000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1412000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16926000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-193000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
22945000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-6640000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-11000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-108000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
683000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3933000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4369000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9683000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-30771000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
278000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62627000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9969000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
69509000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
159745000 usd
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
0 usd
pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
32000000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
12750000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-188858000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21881000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1821000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
149550000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
5750000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1163000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-153465000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-335242000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17329000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-463517000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104139000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
585578000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86810000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122061000 usd
us-gaap Interest Paid Net
InterestPaidNet
20802000 usd
us-gaap Interest Paid Net
InterestPaidNet
14686000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
795000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4104000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3040000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2388000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2454000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
46489000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
39810000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
27696000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
28853000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17945000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27400000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
92130000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
96063000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
308061000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
300992000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
127751000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
117480000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
180310000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183512000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
4700000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
6500000 usd
us-gaap Depreciation
Depreciation
10000000 usd
us-gaap Depreciation
Depreciation
12200000 usd
CY2023Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
3400000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
3300000 usd
CY2023Q2 pcrx Number Of Leases
NumberOfLeases
2 lease
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3631000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3542000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
7259000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
7069000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
378000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
508000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
945000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
980000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
169000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
322000 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
3840000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
4050000 usd
us-gaap Lease Cost
LeaseCost
7882000 usd
us-gaap Lease Cost
LeaseCost
8049000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
7325000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
6637000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M20D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M29D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0703
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0695
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6925000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
13928000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13078000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12814000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12587000 usd
CY2023Q2 pcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
27350000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
86682000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
17655000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
69027000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
163200000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
163200000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
113054000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
477036000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
113054000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
511902000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
84410000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
505680000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
84410000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
540546000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28600000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
28600000 usd
CY2023Q2 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period1
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1
57300000 usd
CY2023Q2 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period2
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2
37400000 usd
CY2023Q2 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period3
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod3
7900000 usd
CY2023Q2 pcrx Finite Lived Intangible Assets Amortization Expense Annual Amount Period4
FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod4
2200000 usd
pcrx Settlement Period Convertible Debt Conversion Request
SettlementPeriodConvertibleDebtConversionRequest
P40D
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3849000 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
8196000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
13199000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
17381000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
691000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
874000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1628000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2053000 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
28000 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
706000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
703000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1412000 usd
CY2023Q2 pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-703000 usd
CY2022Q2 pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-943000 usd
pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-2076000 usd
pcrx Interest Costs Capitalized And Other
InterestCostsCapitalizedAndOther
-1767000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
3865000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
8833000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
13454000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
19079000 usd
CY2023Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0316
CY2022Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0508
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0438
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0531
CY2023Q2 us-gaap Share Price
SharePrice
40.07
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
18259000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
13000000 usd
CY2022 pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Impairments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetImpairments
10000000 usd
CY2022 pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Gain Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
-67000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
21192000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
6758000 usd
pcrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Gain Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyGainLoss
-11000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
27939000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
134465000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
509000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
133956000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
222515000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
25000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
819000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
221721000 usd
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
900000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
800000 usd
pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2022 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
200000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-300000 usd
CY2023Q2 pcrx Share Based Compensation Arrangement By Share Based Payment Award Increase In Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAuthorized
3300000 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10955000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11544000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22945000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22733000 usd
CY2023Q2 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
5742000 usd
CY2022Q2 pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
6542000 usd
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
12206000 usd
pcrx Compensationexpensefromstockoptionsemployees
Compensationexpensefromstockoptionsemployees
13327000 usd
CY2023Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
4969000 usd
CY2022Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
4717000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
10219000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
8830000 usd
CY2023Q2 pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
244000 usd
CY2022Q2 pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
285000 usd
pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
520000 usd
pcrx Compensation Expense From Employee Stock Purchase Plan
CompensationExpenseFromEmployeeStockPurchasePlan
576000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
10955000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
11544000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
22945000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
22733000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1426343 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
39.15
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61896 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
30.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
106927 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
57.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
88438 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
55.06
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7442076 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.22
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
50634 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
25763000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
19876000 usd
us-gaap Net Income Loss
NetIncomeLoss
6227000 usd
us-gaap Net Income Loss
NetIncomeLoss
26704000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
26792000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
20915000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
6227000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
28782000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46088000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45501000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46019000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45185000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52054000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52478000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46285000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52262000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6105000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1979000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11769000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3075000 shares
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
40189000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
23798000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
12416000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
30380000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2335000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1791000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1036000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1079000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
37854000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22007000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11380000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29301000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12091000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2131000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5153000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2597000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.32
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.45
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.09
CY2023Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
0 usd
CY2022Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
950000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
0 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
4065000 usd
CY2023Q2 pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
709000 usd
CY2022Q2 pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
3222000 usd
pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
1198000 usd
pcrx Business Combination Acquisition And Integration Related Costs
BusinessCombinationAcquisitionAndIntegrationRelatedCosts
8630000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
936000 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
936000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q2 pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
16613000 usd
CY2022Q2 pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
18058000 usd
pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
4506000 usd
pcrx Acquisition Related Charges Gains Restructuring Charges And Other
AcquisitionRelatedChargesGainsRestructuringChargesAndOther
13721000 usd
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001396814-23-000037-index-headers.html Edgar Link pending
0001396814-23-000037-index.html Edgar Link pending
0001396814-23-000037.txt Edgar Link pending
0001396814-23-000037-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
paciralimitedlogoa.jpg Edgar Link pending
pcrx-20230630.htm Edgar Link pending
pcrx-20230630.xsd Edgar Link pending
pcrx-20230630_g1.jpg Edgar Link pending
pcrx-20230630_g2.jpg Edgar Link pending
pcrx-6302023xex102.htm Edgar Link pending
pcrx-6302023xex311.htm Edgar Link pending
pcrx-6302023xex312.htm Edgar Link pending
pcrx-6302023xex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
pcrx-20230630_lab.xml Edgar Link unprocessable
pcrx-20230630_pre.xml Edgar Link unprocessable
pcrx-20230630_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pcrx-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pcrx-20230630_cal.xml Edgar Link unprocessable